{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:39:32Z","timestamp":1778521172228,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd007811","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000}}],"reference-count":79,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007811.pub2","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T14:32:42Z","timestamp":1397226762000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sulpiride versus placebo for schizophrenia"],"prefix":"10.1002","volume":"2014","author":[{"given":"Jijun","family":"Wang","sequence":"first","affiliation":[{"name":"Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Department of EEG Source Imaging; Shanghai Shanghai China 200030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Sampson","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health University of Nottingham Innovation Park, Jubilee Campus Nottingham UK NG7 2TU"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD007811.pub2-BIB0001|cit1","first-page":"453","article-title":"Clinical trial with sulpiride and placebo in chronic schizophrenics study of 89 patients using the Harris-Letemendia-Willems scale","volume":"35","author":"Mezquita Blanco","year":"1972","journal-title":"Archivos de Neurobiologi\u00e1 - Madrid"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hup.470050308","article-title":"Sulpiride in negative schizophrenia - a placebo-controlled double-blind assessment","volume":"5","author":"Soni","year":"1990","journal-title":"Human Psychopharmacology Clinical and Experimental"},{"issue":"15","key":"10.1002\/14651858.CD007811.pub2-BIB0003|cit3","first-page":"958","article-title":"Contribution to the clinical study of a new neuroleptic: sulpiride","volume":"45","author":"Benoit","year":"1969","journal-title":"Semaine des H\u00f4pitaux"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00431993","article-title":"Sulpiride in tardive dyskinesia","volume":"66","author":"Casey","year":"1979","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007811.pub2-BIB0005|cit5","first-page":"20","article-title":"A comparison study of using clozapine in combination with sulpiride and simple using clozapine or sulpiride in treatment schizophrenia","volume":"2","author":"Gong","year":"2001","journal-title":"Journal of Chinease Clinical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007811.pub2-BIB0006|cit6","first-page":"141","article-title":"The clinical efficacy of sulpiride in the treatment of type II schizophrenia","volume":"28","author":"Hong","year":"1995","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007811.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-200401000-00004","article-title":"Sulpiride augmentation of olanzapine in the management of treatment-resistant chronic schizophrenia: evidence for improvement of mood symptomatology","volume":"19","author":"Kotler","year":"2004","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007811.pub2-BIB0008|cit8","first-page":"87","article-title":"A control study of clozapine in combination with sulpiride in alleviating the negative symptoms of schizophrenia","volume":"29","author":"Liu","year":"1996","journal-title":"Chinese Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0009|cit9","unstructured":"Ma P Tianma (gastrodia elata B1) for schizophrenia Stanley Foundation Research Programs 2009"},{"issue":"8","key":"10.1002\/14651858.CD007811.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp.47.8.844","article-title":"A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia","volume":"47","author":"Quinn","year":"1984","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"19","key":"10.1002\/14651858.CD007811.pub2-BIB0011|cit11","first-page":"1376","article-title":"Double blind trial of dogmatil in Huntington chorea and tardive dyskinesia","volume":"61","author":"Quinn","year":"1985","journal-title":"Semaine des H\u00f4pitaux"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0012|cit12","unstructured":"Sahakian BJ Sulpiride effects on cognitive function in healthy volunteers National Research Register 2000"},{"issue":"9","key":"10.1002\/14651858.CD007811.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/jnnp.53.9.800","article-title":"Sulpiride in tardive dyskinesia","volume":"53","author":"Schwartz","year":"1990","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1192\/bjp.171.6.569","article-title":"Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study","volume":"171","author":"Shiloh","year":"1997","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007811.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0167-8760(94)90046-9","article-title":"Effect of the dopamine D2 antagonist sulpiride on event-related potentials and its relation to the law of initial value","volume":"16","author":"Takeshita","year":"1994","journal-title":"International Journal of Psychophysiology"},{"issue":"2","key":"10.1002\/14651858.CD007811.pub2-BIB0016|cit16","first-page":"148","article-title":"A clinical effect and following-up study about sulpiride and clozapine for 105 cases of the schizophrenia type ?","volume":"11","author":"Wang","year":"1994","journal-title":"Journal of Xinxiang Medical College"},{"issue":"7","key":"10.1002\/14651858.CD007811.pub2-BIB0017|cit17","first-page":"639","article-title":"Clinical controlled studies of olanzapine combined with sulpiride therapy in refractory schizophrenia","volume":"14","author":"Wu","year":"2005","journal-title":"Chinese Journal of Behavioral Medical Science"},{"issue":"4","key":"10.1002\/14651858.CD007811.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00213-006-0384-5","article-title":"Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia","volume":"186","author":"Wu","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0019|cit19","unstructured":"Wuliji O Eight week double-blind, placebo-controlled, randomized, trial of the traditional Mongolian medical prescription shuangzao mixture added to sulpiride in 200 patients with schizophrenia Stanley Foundation Research Programs 2003"},{"issue":"7","key":"10.1002\/14651858.CD007811.pub2-BIB0020|cit20","first-page":"24","article-title":"Observation on intractable auditory hallucination treated by injecting sulpiride into acupoints","volume":"16","author":"Yang","year":"2000","journal-title":"Journal of Practical Traditional Chinese Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007811.pub2-BIB0021|cit21","first-page":"250","article-title":"A double blind randomized study comparing clozapine and clozapine combination with sulpiride in the treatment of schizophrenia","volume":"12","author":"Yao","year":"1999","journal-title":"Sichuan Mental Health"},{"issue":"3","key":"10.1002\/14651858.CD007811.pub2-BIB0022|cit22","first-page":"224","article-title":"Comparison of sulpiride and chlorpromazine in treatment of negative psychotic symptoms with chronic schizophrenia","volume":"11","author":"Zhao","year":"2003","journal-title":"Health Psychology Journal"},{"issue":"4","key":"10.1002\/14651858.CD007811.pub2-BIB0023|cit23","first-page":"204","article-title":"A controlled trial comparing clomipramine and sulpiride as adjunct to clozapine in the treatment of negative symptoms of schizophrenia","volume":"9","author":"Zhu","year":"1999","journal-title":"Journal of Clinical Psychological Medicine"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0025|cit25","volume-title":"Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1984"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0026|cit26","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD007811.pub2-BIB0027|cit27","first-page":"453","article-title":"The atypical neuroleptic concept","volume":"18","author":"Azorin","year":"1992","journal-title":"Encephale"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"7108","key":"10.1002\/14651858.CD007811.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ (Clinical research ed.)"},{"issue":"4","key":"10.1002\/14651858.CD007811.pub2-BIB0030|cit30","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1979.tb00259.x","article-title":"Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study","volume":"60","author":"Bratfos","year":"1979","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/106002809502900210","article-title":"Sulpiride: an antipsychotic with selective dopaminergic antagonist properties","volume":"2","author":"Caley","year":"1995","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0033|cit33","first-page":"560","article-title":"Study of the effects of sulpiride on the mental state of 40 mental patients","volume":"2","author":"Carrere","year":"1968","journal-title":"Annales Medico Psychologiques Paris"},{"issue":"7","key":"10.1002\/14651858.CD007811.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2471\/BLT.07.045377","article-title":"Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis","volume":"86","author":"Chisholm","year":"2008","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0035|cit35","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Abstracts of 8th International Cochrane Colloquium; 2000 Oct 25-28th Cape Town, South Africa. 2000"},{"issue":"6","key":"10.1002\/14651858.CD007811.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"19","key":"10.1002\/14651858.CD007811.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1192\/bjp.137.6.522","article-title":"Controlled trial of sulpiride in chronic schizophrenic patients","volume":"137","author":"Edwards","year":"1980","journal-title":"British Journal of Psychiatry"},{"issue":"7109","key":"10.1002\/14651858.CD007811.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical research ed.)"},{"issue":"1","key":"10.1002\/14651858.CD007811.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD007811.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archpsyc.60.5.458","article-title":"Placebo or active control trials of antipsychotic drugs?","volume":"60","author":"Fleischhacker","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD007811.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD007811.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/schbul\/17.2.289","article-title":"New antipsychotics: classification, efficacy, and adverse effects","volume":"17","author":"Gerlach","year":"1991","journal-title":"Schizophrenia Bulletin"},{"issue":"9","key":"10.1002\/14651858.CD007811.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0045|cit45","volume-title":"Clinical Global Impression (CGI). In: Early clinical drug evaluation (ECDUE) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"issue":"11","key":"10.1002\/14651858.CD007811.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0048|cit48","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org."},{"issue":"1","key":"10.1002\/14651858.CD007811.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2141.2009.07707.x","article-title":"Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials","volume":"146","author":"Hutton","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0050|cit50","article-title":"Mental disorders","volume-title":"Disease Control Priorities in Developing Countries","author":"Hyman","year":"2006"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0051|cit51","volume-title":"Positive and Negative Syndrome Scale(PANSS) manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Kerwin RW The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research British Journal of Psychiatry 1994 141 8","DOI":"10.1192\/bjp.164.2.141"},{"issue":"4","key":"10.1002\/14651858.CD007811.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0447.1977.tb00174.x","article-title":"A standardized psychiatric assessment scale for rating chronic psychotic patients","volume":"55","author":"Krawiecka","year":"1977","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD007811.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD007811.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007811.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1192\/bjp.169.5.580","article-title":"The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization","volume":"169","author":"Mason","year":"1996","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007811.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0278-5846(94)90067-1","article-title":"L-sulpiride in young and elderly negative schizophrenics: clinical and pharmacokinetic variables","volume":"8","author":"Mauri","year":"1994","journal-title":"Progress in Neuro Psychopharmacology and Biological Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007811.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2165\/00002018-199614050-00003","article-title":"A risk-benefit assessment of sulpiride in the treatment of schizophrenia","volume":"14","author":"Mauri","year":"1996","journal-title":"Drug Safety"},{"issue":"7400","key":"10.1002\/14651858.CD007811.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.326.7400.1171","article-title":"Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications","volume":"326","author":"Melander","year":"2003","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/9780470987353.ch24","article-title":"Acute pharmacological treatment of schizophrenia","volume-title":"Schizophrenia","author":"Myamoto","year":"2003"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0063|cit63","first-page":"164","article-title":"Clinico-pharmacological studies of sulpiride","volume":"20","author":"Nishiura","year":"1976","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD007811.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008126","article-title":"Sulpiride versus other antipsychotics for schizophrenia","author":"Omori Ichiro","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1192\/bjp.136.4.384","article-title":"The disabilities of chronic schizophrenia: their nature and the factors contributing to their development","volume":"136","author":"Owens","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/bmb\/ldm010","article-title":"Mental health in low- and middle-income countries","volume":"81-82","author":"Patel","year":"2007","journal-title":"British Medical Bulletin"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1192\/bjp.150.2.270a","article-title":"The effect of sulpiride on negative symptoms of schizophrenia","volume":"150","author":"Petit","year":"1987","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007811.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003444.pub2","article-title":"Chinese herbal medicine for schizophrenia","author":"Rathbone","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD007811.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009846","article-title":"Sulpiride dose for schizophrenia","author":"Rezk","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007811.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","article-title":"Size of burden of schizophrenia and psychotic disorders","volume":"15","author":"Rossler","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0072|cit72","volume-title":"Modern Psychometrics","author":"Rust","year":"1989"},{"issue":"5","key":"10.1002\/14651858.CD007811.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007811.pub2-BIB0074|cit74","first-page":"359","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2011"},{"issue":"5","key":"10.1002\/14651858.CD007811.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"1","key":"10.1002\/14651858.CD007811.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008125.pub2","article-title":"Sulpiride augmentation for schizophrenia","author":"Wang","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD007811.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD007811.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007811","article-title":"Sulpiride versus placebo for schizophrenia","author":"Omori Ichiro","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007811.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001162","article-title":"Sulpiride for schizophrenia","author":"Soares","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007811.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T04:03:29Z","timestamp":1718769809000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007811.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":79,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007811.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]}}}